{"id":"W2606731929","doi":"10.1016/j.jaad.2017.01.052","title":"Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":192,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"Cilag; LEO Pharma; Astellas Pharma; Regeneron Pharmaceuticals; Celgene; GlaxoSmithKline; Biogen; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Apremilast; Tolerability; Psoriasis; Randomized controlled trial; Safety profile; Pooled analysis; Adverse effect; Dermatology; Internal medicine; Meta-analysis; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03521373,0.002311114,0.007833124,0.002254926,0.0004527971,0.00229401,0.0007910146,0.001660664,0.002959278],"category_scores_gemma":[0.02460575,0.001134401,0.02440763,0.002281074,0.0006375998,0.001763883,0.001122014,0.001783775,0.0003554735],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007666894,"about_ca_system_score_gemma":0.001078746,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000536143,"about_ca_topic_score_gemma":0.001197848,"domain_scores_codex":[0.9814038,0.01066853,0.003531477,0.002177793,0.001806422,0.0004120104],"domain_scores_gemma":[0.9758373,0.01208445,0.008070024,0.002009589,0.001431613,0.0005670435],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.3923099,0.0005283846,0.02557664,0.01463568,0.5227986,0.0001511238,0.0001010667,0.002232072,0.002763144,0.00009443772,0.001048976,0.03776007],"study_design_scores_gemma":[0.2048395,0.04428482,0.1657518,0.001937644,0.5721716,0.0008272192,0.0001201187,0.002458814,0.001663491,0.0007808484,0.004939794,0.0002243193],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5632825,0.4091502,0.01128094,0.0006181864,0.0007280867,0.003803035,0.007469304,0.0005218668,0.003145786],"genre_scores_gemma":[0.9540761,0.03196083,0.003760631,0.0007597149,0.0005629764,0.002599479,0.005468905,0.00008670258,0.0007246583],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03521373,"threshold_uncertainty_score":0.1862302,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01682669124010412,"score_gpt":0.2979934696584649,"score_spread":0.2811667784183608,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}